Iovance Biotherapeutics Inc (NAS:IOVA)
$ 9.4 0.28 (3.07%) Market Cap: 2.86 Bil Enterprise Value: 2.55 Bil PE Ratio: 0 PB Ratio: 3.70 GF Score: 39/100

Q4 2018 Iovance Biotherapeutics Inc Earnings Call Transcript

Feb 27, 2019 / 09:30PM GMT
Release Date Price: $10.65 (+1.91%)
Operator

Good afternoon, and welcome to the Iovance Biotherapeutics Fourth Quarter and year-end 2018 Financial Results Conference Call. (Operator Instructions) Please be advised that the call is being recorded at the company's request. Now I'd like to turn the conference over to Tim Morris, Chief Financial Officer at Iovance. Sir, please go ahead.

Timothy E. Morris
Iovance Biotherapeutics, Inc. - CFO, Principal Accounting Officer, Corporate Secretary & Treasurer

Thank you, operator. Good afternoon, everyone and thanks for joining us today. With me on today's call is Maria Fardis, our President and CEO, and Debora Barton, our SVP of Clinical. This afternoon, we issued a press release that you can find on our website at iovance.com, which includes financial results for the fourth quarter and year ended December 31, 2018, and a corporate update.

Before I turn the call over to Maria, I'd like to remind everyone that statements made during this conference call will include forward-looking statements regarding Iovance's goals, business focus, business plans,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot